Azar Yahyaei

ORCID: 0000-0002-3834-7646 · 8 papers in corpus
rct 2026
Journal of ovarian research ·doi:10.1186/s13048-026-02012-1

BACKGROUND: There is a clear need for new approaches to help women with low ovarian reserve. A new intervention for women with low ovarian reserve is the intra-ovarian injection of platelet-rich plasma (PRP). It is important to comprehensiv…

rct 2026
International journal of fertility & sterility ·doi:10.22074/ijfs.2025.2054284.1828

OBJECTIVE: Experimental evidence suggests that the human endometrium expresses receptors for human chorionic gonadotropin (hCG), and activation of these receptors may enhance embryo implantation. Numerous studies have explored the effects o…

observational 2026
BMC women's health ·doi:10.1186/s12905-026-04589-7

BACKGROUND: This study intended to investigate the relationship between the hormone receptors (including estrogen and progesterone receptors (ER/PR), and human epidermal growth factor receptor-2 (HER2) or triple-negative breast cancer (TNBC…

rct 2024
Scientific reports ·doi:10.1038/s41598-024-77578-1

The studies posits that there is not sufficient evidence to support the use of intrauterine platelet-rich plasma (PRP) infusion in patients with recurrent implantation failure (RIF). This study aims to investigate the effects of infusion of…

observational 2023
Journal of ovarian research ·doi:10.1186/s13048-023-01149-7

BACKGROUND: Ovarian reserve is a crucial indicator of a woman's fertility potential, which is determined by the quality and quantity of antral follicles and oocytes. However, certain factors such as endometriosis, pelvic inflammatory diseas…

rct 2023
BMC women's health ·doi:10.1186/s12905-023-02473-2

BACKGROUND: Currently, optimal method of ovarian stimulation (OS) to in-vitro fertilization (IVF) in the patients with polycystic ovarian syndrome (PCOS) is unknown. The present research aims to study the efficiency of minimal-OS method in …

case-report 2023
Cell journal ·doi:10.22074/cellj.2023.2000360.1289

Today, timely diagnosis and therapeutic progress open a road of hope for survival in cancerous patients. Increased knowledge about the various cytotoxic treatment's impacts on ovarian function and fertility has resulted in a surge in the nu…

rct 2018
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-018-0442-y

BACKGROUND: Recently, a novel approach with delaying the start of controlled ovarian stimulation along with gonadotropin-releasing hormone (GnRH) antagonist pretreatment for 7 days after estrogen priming for further suppression of endogenou…